NR3C2 and cardiovascular disorder: The search terms used were as follows: "empagliflozin", "dapagliflozin", "canagliflozin", "ertugliflozin", "sotagliflozin", "sodium-glucose transporter 2 inhibitors", "spironolactone", "eplerenone", "finerenone", "mineralocorticoid receptor antagonists", "heart failure", and "cardiovascular diseases".